Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

University of Adelaide to conduct phase I study of AmpliPhi's AB-SA01

Nov. 24, 2015

Spring Bank plans phase II trial of SB-9200 and Viread in HBV infection

Nov. 24, 2015

Imperial Innovations Group discloses anthrax vaccine

Nov. 20, 2015

Oragenics completes pre-IND meeting for OG-253

Nov. 20, 2015

Jiangsu Kanion Pharmaceutical and Medshine Discovery report anti-EV71 compounds

Nov. 18, 2015

MGB Biopharma completes feasibility study of topical MGB-BP-3

Nov. 18, 2015

Protagen and Mikrogen agree on codevelopment program for Lyme disease diagnostic assay

Nov. 17, 2015

Novartis discloses vaccine adjuvants

Nov. 17, 2015

Targeting Leishmania PEPCK protects mice from parasite challenge

Nov. 17, 2015

Amplyx Pharmaceuticals secures funding to advance APX-001

Nov. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...